Neuroprotective effects of estradiol-17beta: implications for psychiatric disorders.
Arch Womens Ment Health
; 5(3): 105-10, 2002 Nov.
Article
em En
| MEDLINE
| ID: mdl-12510213
ABSTRACT
Estradiol-17beta is the most potent female sex hormone. In addition to its role in the control of primary and secondary sexual characteristics, it also influences the development of the brain. Furthermore, estradiol-17beta possesses neuroprotective properties that are mediated via receptor action and also independently of receptors. Several processes that are regulated by estradiol-17beta might influence the expression of Alzheimer's disease and schizophrenia. Differences between the sexes have been described in both disorders, and it has been suggested that these may be due to the action of oestrogens. Long-term oestrogen replacement has proved to be beneficial in the prevention and treatment of Alzheimer's disease and schizophrenia. The results, however, are controversial. Preliminary in vitro and in vivo findings, which are summarised in this review, encourage further studies with estradiol-17beta or its analogues as potential adjunctive interventions particularly in "negative syndrome" schizophrenia and in Alzheimer's disease.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esquizofrenia
/
Fármacos Neuroprotetores
/
Estradiol
/
Doença de Alzheimer
Limite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Arch Womens Ment Health
Assunto da revista:
PSICOLOGIA
/
SAUDE DA MULHER
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Alemanha